LSO Medical Announces CE Approval of Next-Gen LUMESEAL Laser for Treatment of Varicose Vein.

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

LSO Medical Announces CE Approval of Next-Gen LUMESEAL Laser for Treatment of Varicose Vein.

LUMESEAL® Adds SnakeBack® to Enhance Ease-of-Use and Control

Canada NewsWire

LILLE, France, Sept. 21, 2021 /CNW/ -- LSO MEDICAL SAS, international leader in vascular laser therapies, announced today the CE Approval of its newest generation EVLT SnakeBack® assisted system, the LUMESEAL® laser platform. Designed to enhance ease-of-use and to provide greater precision and control throughout the procedure, Lumeseal is announced as the successor of the efficient and widely used ENDOTHERME 1470 platform.

The third-generation laser system incorporates the same 1470nm laser design combined with the RINGLIGHT® fibers range design which has shown superior performance and clinical evidence compared to other alternative configurations. In addition, LUMESEAL® incorporates the last patented innovation of the company: the SnakeBack® technology. SnakeBack® is a  tensionless assisted pullback system,  able to plan, apply and monitor energy profiles delivery into the vein.  Based on its assisted pullback feature, and its laser driver interface, the full integration of SnakeBack® together with the BackReflection features of Endotherme 1470 allows a total supervision of the vein occlusion, while maintaining the usual touch feel feedback during procedure.

"The integration of SnakeBack® technology on LUMESEAL® is a big step forward for the development of the technique. Beyond its direct impact on enhancing the reproducibility and comfort of laser delivery, the LUMESEAL®  platform allows us to assess further improvements in the EVLT technique (new wavelengths, applicators, ...) "says M. Rochon, LSO Medical CEO.

Limited commercial release due to the international shortage around the semiconductor is planned for the fall with a full launch anticipated in early 2022.

About LSO Medical

With more than 20 years' experience, the French company LSO Medical is a key player in the design, production and marketing of innovative medical laser systems.

Constantly aiming at exploiting and bringing technological innovations to doctors and their patients, LSO Medical is today one of the world leaders in the endothermic laser technique.


To learn more about the laser LUMESEAL® and/or the SnakeBack® technology: [email protected]

Logo -

Cision View original content to download multimedia:


Cision View original content to download multimedia:

Copyright CNW Group 2021

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).